QTREX Quantum Ltd. QTEX

Annual Quarterly

FY2025 · ended Dec 31, 2025 · Revenue $289,000 · Filed Mar 26, 2026

QTREX Quantum Ltd. (QTEX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $289,000 and a net loss of $13.2 million. Free cash flow was -$10.0 million. As of Dec 31, 2025 it held $3.2 million in cash and investments and $480,000 in total debt.

Revenue
$289,000
Net income
$-13.22M
-19.6% vs prior year
Operating cash flow
$-9.86M
-5.2% vs prior year
Free cash flow
$-9.96M
-4.5% vs prior year
EPS
$-0.45
+25.0% vs prior year
Dividend per share
None
Shares outstanding
35.95M
+48.2% vs prior year
Net cash
$2.68M
FY 2025
Operating margin
-4713.8%
FY 2025

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
QTEX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Ra'Anana
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1837493
Former names
Inspira Technologies OXY B.H.N. Ltd (until May 19, 2026)

Other Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
Revenue
$289,000
—
—
Operating income
-$13.6M
-$11.3M
-$12.1M
Net income
-$13.2M
-$11.1M
-$11.3M
Diluted EPS
-$0.45
-$0.60
-$0.93
Operating cash flow
-$9.9M
-$9.4M
-$9.7M
Free cash flow
-$10.0M
-$9.5M
-$9.9M
Total assets
$5.3M
$8.1M
$9.3M
Stockholders' equity
$2.3M
$4.3M
$5.7M
Cash and investments
$3.2M
$5.8M
$7.3M
Total debt
$480,000
$655,000
$878,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 19, 2026 Oct 19, 2026
6-K Current report (foreign issuer) Oct 9, 2026 Oct 9, 2026
6-K Current report (foreign issuer) Oct 1, 2026 Oct 1, 2026
6-K Current report (foreign issuer) Sep 24, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Sep 2, 2026 Sep 2, 2026
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.